{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ERK", "JNK", "apoptosis", "cell cycle arrest", "norcantharidin", "p38 MAPK", "renal cancer cells"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33151174", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2478/acph-2021-0012"], "Journal": {"ISSN": "1846-9558", "JournalIssue": {"Volume": "71", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Jun", "Day": "01"}}, "Title": "Acta pharmaceutica (Zagreb, Croatia)", "ISOAbbreviation": "Acta Pharm"}, "ArticleTitle": "Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.", "Pagination": {"StartPage": "267", "EndPage": "278", "MedlinePgn": "267-278"}, "Abstract": {"AbstractText": ["Renal cell carcinoma (RCC) is generally acknowledged as the most resistant primary malignancy unresponsive to conventional radiotherapy and chemotherapy treatments. Norcantharidin (NCTD), a therapeutic compound derived from medicinal plants, has been shown to trigger apoptosis, as well as antimetastatic and antioxidant activities in several tumor cells. However, NCTD's mechanism of antitumor activity in the RCC cell line remains unclear. In this study, we report that NCTD led to a time- and dose-dependent inhibition of cell proliferation. It had also markedly induced apoptosis and G2/M phase cell cycle arrest in a dose-dependent manner by decreasing the expressions of pro-caspase-3, pro-caspase-9, cyclin B1, and pCDC25C while increasing active caspase-3, cleaved-PARP, P21, and pCDC2 levels. Interestingly, NCTD treatment provoked the phosphorylation of extracellular-regulated protein kinase (ERK) and c-Jun-N-terminal kinase (JNK), but not of p38 MAPK. Moreover, SCH772984 and SP600125, ERK and JNK inhibitors, respectively, could partially abolish NCTD-induced apoptosis and G2/M phase cell cycle arrest. Collectively, these findings suggest that NCTD might activate JNK and ERK signaling pathways, consequently inducing apoptosis and G2/M arrest through the modulation of related proteins. This study provided evidence that NCTD is a promising therapeutic drug for the treatment of RCC."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Renal Carcinoma, Ningbo Yinzhou No. 2 Hospital, Ningbo 315100, Zhejiang, P.R.China."}, {"Identifier": [], "Affiliation": "Zhejiang Key Laboratory of Pathophysiology, Ningbo University, Ningbo 315211, Zhejiang, P.R.China."}], "LastName": "Huang", "ForeName": "Shuaishuai", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhejiang Key Laboratory of Pathophysiology, Ningbo University, Ningbo 315211, Zhejiang, P.R.China."}], "LastName": "Tuergong", "ForeName": "Gulimire", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhejiang Key Laboratory of Pathophysiology, Ningbo University, Ningbo 315211, Zhejiang, P.R.China."}], "LastName": "Zhu", "ForeName": "Hangjie", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Renal Carcinoma, Ningbo Yinzhou No. 2 Hospital, Ningbo 315100, Zhejiang, P.R.China."}, {"Identifier": [], "Affiliation": "Zhejiang Key Laboratory of Pathophysiology, Ningbo University, Ningbo 315211, Zhejiang, P.R.China."}], "LastName": "Wang", "ForeName": "Xue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Renal Carcinoma, Ningbo Yinzhou No. 2 Hospital, Ningbo 315100, Zhejiang, P.R.China."}], "LastName": "Weng", "ForeName": "Guobin", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Renal Carcinoma, Ningbo Yinzhou No. 2 Hospital, Ningbo 315100, Zhejiang, P.R.China."}], "LastName": "Ren", "ForeName": "Yu", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "Acta Pharm", "NlmUniqueID": "9303678", "ISSNLinking": "1330-0075"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Bridged Bicyclo Compounds, Heterocyclic"}, {"RegistryNumber": "8452E71EO7", "NameOfSubstance": "norcantharidin"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "p38 Mitogen-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Bridged Bicyclo Compounds, Heterocyclic"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Carcinoma, Renal Cell"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Kidney Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "M Phase Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "p38 Mitogen-Activated Protein Kinases"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "1. R. L. Siegel, K. D. Miller and A. Jemal, Cancer statistics, CA Cancer J. Clin.68 (2018) 7\u201330; https://doi.org/10.3322/caac.2144210.3322/caac.21442"}, {"Citation": "2. M. Sun, G. Lughezzani, P. Perrotte and P. I. Karakiewicz, Treatment of metastatic renal cell carcinoma, Nat. Rev. Urol.7 (2010) 327\u2013338; https://doi.org/10.1038/nrurol.2010.5710.1038/nrurol.2010.57"}, {"Citation": "3. X. Wang, Y. Ren, H. Zhuang, X. Meng, S. Huang, Y. Li, M. Hehir and P. Wang, Decrease of phosphorylated proto-oncogene CREB at Ser 133 site inhibits growth and metastatic activity of renal cell cancer, Expert Opin. Ther. Targets19 (2015) 985\u2013995; https://doi.org/10.1517/14728222.2015.105320810.1517/14728222.2015.1053208"}, {"Citation": "4. W. W. An, X. F. Gong, M. W. Wang, S. Tashiro, S. Onodera and T. Ikejima, Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways, Acta Pharmacol. Sin.25 (2004) 1502\u20131508; https://doi.org/10.1016/S0898-6568(03)00096-210.1016/S0898-6568(03)00096-2"}, {"Citation": "5. Y. Ren, S. W. Zhang, Z. H. Xie, X. M. Xu, L. L. Chen, Z. G. Lou, G. B. Weng and X. P. Yao, Cantharidin induces G2/M arrest and triggers apoptosis in renal cell carcinoma, Mol. Med. Rep.14 (2016) 5614\u20135618; https://doi.org/10.3892/mmr.2016.596310.3892/mmr.2016.596327878266"}, {"Citation": "6. M. N. Jahnke, S. Hwang, J. L. Griffith and T. Shwayder, Cantharidin for treatment of facial molluscum contagiosum: A retrospective review, J. Am. Acad. Dermatol.78 (2018) 198\u2013200; https://doi.org/10.1016/j.jaad.2017.08.04410.1016/j.jaad.2017.08.04429241785"}, {"Citation": "7. F. Massicot, H. Dutertre-Catella, C. Pham-Huy, X. H. Liu, H. T. Duc and J. M. Warnet, In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin, Basic Clin. Pharmacol. Toxicol.96 (2005) 26\u201332; https://doi.org/10.1111/j.1742-7843.2005.pto960104.x10.1111/j.1742-7843.2005.pto960104.x15667592"}, {"Citation": "8. S. H. Kok, S. J. Cheng, C. Y. Hong, J. J. Lee, S. K. Lin, Y. S. Kuo, C. P. Chiang and M. Y. Kuo, Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio, Cancer Lett.217 (2005) 43\u201352; https://doi.org/10.1016/j.canlet.2004.07.04510.1016/j.canlet.2004.07.04515596295"}, {"Citation": "9. C. H. Hsia, W. J. Lu, K. H. Lin, D. S. Chou, P. Geraldine, T. Jayakuma, N. C. Chang and J. R. Sheu, Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin alphaIIb beta3 binding in human platelets, J. Cell Mol. Med.22 (2018) 2142\u20132152; https://doi.org/10.1111/jcmm.1348810.1111/jcmm.13488586711629369482"}, {"Citation": "10. Y. Li, Q. Chen, F. Y. Liu, Y. M. Peng, T. Hou, S. B. Duan, J. Li, J. H. Luo, L. Sun and G. H. Ling, Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy, Ren. Fail.33 (2011) 233\u2013241; https://doi.org/10.3109/0886022X.2011.55330510.3109/0886022X.2011.55330521332346"}, {"Citation": "11. T. Yu, F. Hou, M. Liu, L. Zhou, D. Li, J. Liu, Z. Fan and Q. Li, Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer, Asian Pac. J. Cancer Prev.13 (2012) 499\u2013503; https://doi.org/10.7314/APJCP.2012.13.2.49910.7314/APJCP.2012.13.2.49922524814"}, {"Citation": "12. H. Lv, Y. Li, H. Du, J. Fang, X. Song and J. Zhang, The synthetic compound norcantharidin induced apoptosis in mantle cell lymphoma in vivo and in vitro through the PI3K-Akt-NF- kappa B signaling pathway, Evid. Based Complement Alternat. Med.2013 (2013) 461487; https://doi.org/10.1155/2013/46148710.1155/2013/461487372298023935664"}, {"Citation": "13. Q. Y. Zhang, X. Q. Yue, Y. P. Jiang, T. Han and H. L. Xin, FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells, Sci. Rep.7 (2017) 396; https://doi.org/10.1038/s41598-017-00313-610.1038/s41598-017-00313-6542825828341836"}, {"Citation": "14. P. Y. Yang, M. F. Chen, Y. H. Kao, D. N. Hu, F. R. Chang and Y. C. Wu, Norcantharidin induces apoptosis of breast cancer cells: involvement of activities of mitogen activated protein kinases and signal transducers and activators of transcription, Toxicol. In Vitro25 (2011) 699\u2013707; https://doi.org/10.1016/j.tiv.2011.01.01110.1016/j.tiv.2011.01.01121266192"}, {"Citation": "15. C. L. Lin, C. M. Chen, C. L. Lin, C. W. Cheng, C. H. Lee and Y. H. Hsieh, Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells, Biochim. Biophys. Acta1864 (2017) 1867\u20131876; https://doi.org/10.1016/j.bbamcr.2017.07.01510.1016/j.bbamcr.2017.07.01528760656"}, {"Citation": "16. Z. Wang, D. You, M. Lu, Y. He and S. Yan, Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression, Oncol. Lett.13 (2017) 1660\u20131664; https://doi.org/10.3892/ol.2017.562210.3892/ol.2017.5622540326728454306"}, {"Citation": "17. M. Y. Huang, L. L. Zhang, J. Ding and J. J. Lu, Anticancer drug discovery from Chinese medicinal herbs, Chin. Med.13 (2018) 35; https://doi.org/10.1186/s13020-018-0192-y10.1186/s13020-018-0192-y603119429997684"}, {"Citation": "18. A. A. Nagle, F. F. Gan, G. Jones, C. L. So, G. Wells and E. H. Chew, Induction of tumor cell death through targeting tubulin and evoking dysregulation of cell cycle regulatory proteins by multi-functional cinnamaldehydes, PLoS One7 (2012) e50125; https://doi.org/10.1371/journal.pone.005012510.1371/journal.pone.0050125350376123185555"}, {"Citation": "19. S. C. Biswas, P. Sanphui, N. Chatterjee, S. Kemeny and L. A. Greene, Cdc25A phosphatase: a key cell cycle protein that regulates neuron death in disease and development, Cell Death Dis.8 (2017) e2692; https://doi.org/10.1038/cddis.2017.11510.1038/cddis.2017.115538652128333146"}, {"Citation": "20. J. Wang and Y. F. Jiang, Natural compounds as anticancer agents: Experimental evidence, World J. Exp. Med.2 (2012) 45\u201357; https://doi.org/10.5493/wjem.v2.i3.4510.5493/wjem.v2.i3.45390558324520533"}, {"Citation": "21. N. Bailon-Moscoso, G. Cevallos-Solorzano, J. C. Romero-Benavides and M. I. Orellana, Natural compounds as modulators of cell cycle arrest: Application for anticancer chemotherapies, Curr. Genomics.18 (2017) 106\u2013131; https://doi.org/10.2174/138920291766616080812564510.2174/1389202917666160808125645534533328367072"}, {"Citation": "22. M. Brentnall, L. Rodriguez-Menocal, R. L. De Guevara, E. Cepero and L. H. Boise, Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis, BMC Cell Biol.14 (2013) 32; https://doi.org/10.1186/1471-2121-14-3210.1186/1471-2121-14-32371024623834359"}, {"Citation": "23. J. Kale, E. J. Osterlund and D. W. Andrews, BCL-2 family proteins: changing partners in the dance towards death, Cell Death Differ.25 (2018) 65\u201380; https://doi.org/10.1038/cdd.2017.18610.1038/cdd.2017.186572954029149100"}, {"Citation": "24. W. W. Chu, X. Y. He, A. L. Yan, S. W. Wang, S. Li, S. Nian, Y. L. Wang and F. L. Liang, Ischemic postconditioning lightening ischemia/reperfusion apoptosis of rats via mitochondria pathway, Eur. Rev. Med. Pharmacol. Sci.23 (2019) 6307\u20136314; https://doi.org/10.26355/eurrev_201907_18453"}, {"Citation": "25. H. K. An, K. M. Chung, H. Park, J. Hong, J. E. Gim, H. Choi, Y. W. Lee, J. Choi, J. Y. Mun and S. W. Yu, CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis, Autophagy (2019) 1\u201320; https://doi.org/10.1080/15548627.2019.169539810.1080/15548627.2019.1695398838660831818185"}, {"Citation": "26. C. L. Cusack, V. Swahari, W. H. Henley, J. M. Ramsey and M. Deshmukh, Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning, Nat. Commun.4 (2013) 1876; https://doi.org/10.1038/ncomms291010.1038/ncomms2910418306123695670"}, {"Citation": "27. G. Pearson, F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman and M. H. Cobb, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr. Rev.22 (2001) 153\u2013183; https://doi.org/10.1210/edrv.22.2.042810.1210/edrv.22.2.042811294822"}, {"Citation": "28. Y. Sun, W. Z. Liu, T. Liu, X. Feng, N. Yang and H. F. Zhou, Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis, J. Recept. Signal Transduct. Res.35 (2015) 600\u2013604; https://doi.org/10.3109/10799893.2015.103041210.3109/10799893.2015.103041226096166"}, {"Citation": "29. T. Chen and Y. S. Wong, Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation, J. Agric. Food Chem.56 (2008) 10574\u201310581; https://doi.org/10.1021/jf802125t10.1021/jf802125t18959417"}, {"Citation": "30. W. Liu, R. Ning, R. N. Chen, X. F. Huang, Q. S. Dai, J. H. Hu, Y. W. Wang, L. L. Wu, J. Xiong, G. Hu, Q. L. Guo, J. Yang and H. Wang, Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells, Mol. Carcinog.55 (2016) 440\u2013457; https://doi.org/10.1002/mc.2229310.1002/mc.2229325683703"}, {"Citation": "31. Y. Tsuchiya, S. Murai and S. Yamashita, Dual inhibition of Cdc2 protein kinase activation during apoptosis in Xenopus egg extracts, FEBS J.282 (2015) 1256\u20131270; https://doi.org/10.1111/febs.1321710.1111/febs.1321725631627"}, {"Citation": "32. W. J. Sun, H. Huang, B. He, D. H. Hu, P. H. Li, Y. J. Yu, X. H. Zhou, Z. Lv, L. Zhou, T. Y. Hu, Z. C. Yao, M. D. Lu, X. Shen and Z. Q. Zheng, Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepato-cellular carcinoma cells, Biochem. Pharmacol.127 (2017) 90\u2013100; https://doi.org/10.1016/j.bcp.2016.12.00810.1016/j.bcp.2016.12.00828012958"}, {"Citation": "33. X. Grana and E. P. Reddy, Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs), Oncogene11 (1995) 211\u2013219."}, {"Citation": "34. N. Kaushal and M. P. Bansal, Inhibition of CDC2/Cyclin B1 in response to selenium-induced oxidative stress during spermatogenesis: potential role of Cdc25c and p21, Mol. Cell Biochem.298 (2007) 139\u2013150; https://doi.org/10.1007/s11010-006-9360-y10.1007/s11010-006-9360-y17160696"}, {"Citation": "35. Y. C. Cho, J. E. Park, B. C. Park, J. H. Kim, D. G. Jeong, S. G. Park and S. Cho, Cell cycle-dependent Cdc25C phosphatase determines cell survival by regulating apoptosis signal-regulating kinase 1, Cell Death Differ.22 (2015) 1605\u20131617; https://doi.org/10.1038/cdd.2015.210.1038/cdd.2015.2456378625633196"}, {"Citation": "36. Y. S. Sun, L. X. Lv, Z. Zhao, X. He, L. You, J. K. Liu and Y. Q. Li, Cordycepol C induces caspase-independent apoptosis in human hepatocellular carcinoma HepG2 cells, Biol. Pharm. Bull.37 (2014) 608\u2013617; https://doi.org/10.1248/bpb.b13-0087710.1248/bpb.b13-0087724694607"}, {"Citation": "37. M. Gaestel, MAPK-activated protein kinases (MKs): Novel insights and challenges, Front Cell Dev. Biol.3 (2015) 88; https://doi.org/10.3389/fcell.2015.0008810.3389/fcell.2015.00088470522126779481"}, {"Citation": "38. Z. Han, B. Li, J. Wang, X. Zhang, Z. Li, L. Dai, M. Cao and J. Jiang, Norcantharidin inhibits SK-NSH neuroblastoma cell growth by induction of autophagy and apoptosis, Technol. Cancer Res. Treat.16 (2017) 33\u201344; https://doi.org/10.1177/153303461562458310.1177/1533034615624583561611226755751"}, {"Citation": "39. Y. N. Chen, C. C. Cheng, J. C. Chen, W. Tsauer and S. L. Hsu, Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells, Br. J. Pharmacol.140 (2003) 461\u2013470; https://doi.org/10.1038/sj.bjp.070546110.1038/sj.bjp.0705461157405212970086"}], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "4", "Day": "15"}, {"Year": "2020", "Month": "11", "Day": "5", "Hour": "12", "Minute": "12"}, {"Year": "2020", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "31", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33151174", "10.2478/acph-2021-0012", "acph-2021-0012"]}}]}